Carbamazepine/chloral hydrate

February 2008
Reactions Weekly;2/23/2008, Issue 1190, p10
Case Study
The article describes the case of a 43-year-old woman, who had bipolar and emotional unstable personality disorder and developed purpura and ecchymosis over her whole body while receiving carbamazepine and chloral hydrate. The patient subsequently experienced a depressive episode and was treated with carbamazepine and chloral hydrate. Information is given on the dosage of the drugs taken by the patient. The drug were discontinued and blood tests revealed a slightly reduced, but still normal, partial thromboplastin time.


Related Articles

  • Carbamazepine.  // Reactions Weekly;11/14/2009, Issue 1278, p12 

    The article describes the case of a 26-year-old man with bipolar disorder who experienced symptomatic hyperammonaemia during his treatment with carbamazepine. His medical history included seizure disorder secondary to brain trauma, multiple sclerosis, unilateral blindness and mild mental...

  • Acetazolamide.  // Reactions Weekly;1/29/2005, Issue 1036, p6 

    Presents the case of a 67-year-old man who developed thrombocytopenia following treatment with acetazolamide. Outcome of routine blood tests performed on the patient; Background on the development of extensive purpura in the patient after receiving acetazolamide.

  • Lithium interaction.  // Reactions Weekly;9/18/2004, Issue 1019, p11 

    Discusses research being done on the side effects of lithium with rofecoxib in an elderly patient with bipolar disorder. Reference to a study by S. Crespo and colleagues published in the July to August 2004 issue of "Annals of Pharmacotherapy"; Occurrence of lithium intoxication; Clinical...

  • Sibutramine.  // Reactions Weekly;3/14/2009, Issue 1243, p40 

    The article presents a case study of a 27-year-old woman with bipolar I disorders who had been asymptomatic for 18 months while receiving carbamazepine and risperidone. The patient started receiving sibutramine for obesity. She presented with irritability, increased energy and frenzied activity...

  • Carbamazepine withdrawal.  // Reactions Weekly;5/19/2007, Issue 1152, p8 

    The article describes the case of an older man with bipolar I disorder who experienced bipolar switching after sudden discontinuation of carbamazepine. The patient showed symptoms such elevated mood and irritability after taking the drug. Olanzapine, perazine, and lamotrigine were effective in...

  • Anticonvulsant hypersensitivity syndrome: a rare and serious complication. Schweitzer, Isaac // Medical Journal of Australia;6/6/2011, Vol. 194 Issue 11, p609 

    The article discusses the case of a patient who experienced anticonvulsant hypersensitivity syndrome (ACHS) following administration of carbamazepine for bipolar disorder with symptoms of mania. Particular focus is given to her medications and the side effects of carbamazepine. The patient's...

  • Influenza virus vaccine.  // Reactions Weekly;2/12/2011, Issue 1338, p24 

    The article describes the case of a 4-year-old girl who developed purpura rheumatica and intussusception following administration of an influenza A (H1N1) virus vaccine.

  • Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepine. Eguchi, Eriko; Shimazu, Keiji; Nishiguchi, Kensuke; Yorifuji, Soushi; Tanaka, Atsuo; Kuwahara, Takashi // Clinical & Experimental Nephrology;Feb2012, Vol. 16 Issue 1, p168 

    We report the case of a 70-year-old female patient with granulomatous interstitial nephritis (GIN) induced by carbamazepine (CBZ). The patient had a 22-year history of bipolar disorder. Approximately 50 days before admission to our hospital, she was switched from valproic acid to 200 mg/day CBZ...

  • CARBAMAZEPINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p224 

    The article presents information on carbamazepine, an analgesic, anticonvulsant, and antimanic agent, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics